Cardiovascular Research

Aims & Scope

Cardiovascular Research is the international journal of the European Society of Cardiology for basic and translational research, spanning all topics within cardiology and cardiovascular biology.

The journal aims to enhance insight into cardiovascular disease mechanisms and the prospects for innovation.

The journal welcomes submission of papers both at the molecular, sub-cellular, cellular, organ, and organism level, and of clinical proof-of-concept and translational studies.

Manuscripts are expected to provide a significant contribution to the field with relevance for cardiovascular biology and diseases.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	13.3
2024	10.20

SJR (SCImago Journal Rank)

Year	Value
2024	3.947

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	251

Journal Rank

Year	Value
2024	433

Journal Citation Indicator

Year	Value
2024	8380

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Structure and function of matrix metalloproteinases and TIMPs

  Citation: 2602

  Authors: H, R, G

• Global burden of heart failure: a comprehensive and updated review of epidemiology

  Citation: 1971

  Authors: Gianluigi, Peter Moritz, Lars H, Petar, Giuseppe M C, Andrew J S

• The inflammatory response in myocardial infarction

  Citation: 1596

  Authors: N

• Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

  Citation: 1339

  Authors: W, L, A, W, I, S, P, I, A, R

• Electrical, contractile and structural remodeling during atrial fibrillation

  Citation: 1110

  Authors: M

• Morphologic and biochemical hallmarks of apoptosis

  Citation: 1104

  Authors: A

• COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

  Citation: 1087

  Authors: Tomasz J, Saidi A, Anthony, Vimal, Kostas, Federica M, Meena S, Maciej, Pasquale, Fulvio, Stuart A, Ali J, Ryszard, Eleanor C, Bartlomiej, Colin, Rhian M, Reinhold, Dao Wen, David, Orlando, Filippo, Emma C, Iain B

• Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection

  Citation: 939

  Authors: A

• The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

  Citation: 909

  Authors: Liang, Xiangjie, Mingquan, Yi, Chenglong

• Cardiac fibrosis

  Citation: 866

  Authors: Nikolaos G

---